Ciclosporin use in acute ulcerative colitis: a long-term experience

被引:151
作者
Campbell, S [1 ]
Travis, S [1 ]
Jewell, D [1 ]
机构
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
ulcerative colitis; ciclosporin; azathioprine; colectomy; inflammatory bowel disease;
D O I
10.1097/00042737-200501000-00016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Within a lifetime, approximately 15% of ulcerative colitis (UC) patients will have a severe relapse necessitating admission to hospital. Despite intravenous steroid treatment, approximately 25% will require either surgery or ciclosporin (CsA) rescue therapy. Initial response rates to CsA have been encouraging, but remission rates have been disappointing. There is a paucity of long-term data on UC patients who have been brought into remission with CsA. Objectives To report our 7 year experience on the use of CsA in acute UC and to highlight long-term follow-up data on these patients. Patients and methods A retrospective database of 76 UC patients requiring CsA between 1996 and 2003 was constructed. CsA was started on the basis of their C-reactive protein (CRP) and/or stool frequency after 3 days or after 5-7 days of i.v. hydrocortisone. The patients (33 female, 43 male, mean age 44.5 years) were followed up for a median 2.9 years (range 0.2-7.0 years). Fifty-four patients received i.v. CsA (4 mg/kg), while 22 received oral CsA (5 mg/kg). Long-term outcome was evaluated by Kaplan-Meier survival analysis: time to first relapse and time to surgery. Results Median disease duration was 6.6 years. Median CRP and stool frequency at day 3 was 20 mg/l and 6 per day, respectively. Fifty-six patients (74%) achieved initial remission. CsA was discontinued in only four patients due to side effects. Duration of i.v. steroids or the addition of AZA did not improve time to first relapse or time to surgery. Comparison between i.v. CsA and oral CsA revealed a statistically significant difference in time to first relapse (P < 0.01) and time to surgery (P < 0.05) in favour of oral CsA. Conclusions These data describe the long-term outcome of the largest series of patients so far reported that have had treatment with CsA for severe refractory UC. If patients achieved initial remission with CsA, after 1 year, 65% had relapsed and after 3 years 90% had relapsed. After 7 years, 58% had come to colectomy. Minor side effects were frequent, but none were life threatening. There was no increase in post-operative complications in those who came to colectomy. (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 14 条
  • [1] Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial
    Actis, GC
    Aimo, G
    Priolo, G
    Moscato, D
    Rizzetto, M
    Pagni, R
    [J]. INFLAMMATORY BOWEL DISEASES, 1998, 4 (04) : 276 - 279
  • [2] Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis
    Actis, GC
    Bresso, F
    Astegiano, M
    Demarchi, B
    Sapone, N
    Boscaglia, C
    Rizzetto, M
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) : 1307 - 1311
  • [3] Arts J, 2001, GASTROENTEROLOGY, V120, pA624
  • [4] BAKER K, 1989, ALIMENT PHARM THERAP, V3, P143
  • [5] Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome
    Campbell, S
    Ghosh, S
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (08) : 546 - 551
  • [6] Cohen RD, 1999, AM J GASTROENTEROL, V94, P1587
  • [7] DHAENS G, 2001, GASTROENTEROLOGY, V120, P1541
  • [8] Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications
    Hyde, GM
    Jewell, DP
    Kettlewell, MGW
    Mortensen, NJMC
    [J]. DISEASES OF THE COLON & RECTUM, 2001, 44 (10) : 1436 - 1440
  • [9] JARNEROT G, 1985, GASTROENTEROLOGY, V89, P1005
  • [10] CYCLOSPORINE IN SEVERE ULCERATIVE-COLITIS REFRACTORY TO STEROID-THERAPY
    LICHTIGER, S
    PRESENT, DH
    KORNBLUTH, A
    GELERNT, I
    BAUER, J
    GALLER, G
    MICHELASSI, F
    HANAUER, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) : 1841 - 1845